Literature DB >> 22947579

Variation in use of the 2-week referral pathway for suspected cancer: a cross-sectional analysis.

David Meechan1, Carolynn Gildea, Louise Hollingworth, Mike A Richards, Di Riley, Greg Rubin.   

Abstract

BACKGROUND: A 2-Week Wait (2WW) referral pathway for earlier diagnosis of suspected cancer was introduced in England in 2000. Nevertheless, a significant proportion of patients with cancer are diagnosed by other routes (detection rate), only a small proportion of 2WW referrals have cancer (conversion rate) and there is considerable between-practice variation. AIM: This study examined use by practices of the 2WW referral in relation to all cancer diagnoses. DESIGN AND
SETTING: A cross-sectional analysis of data extracted from the Cancer Waiting Times Database for all 2WW referrals in 2009 and for all patients receiving a first definitive treatment in the same year.
METHOD: The age standardised referral ratio, conversion rate, and detection rate were calculated for all practices in England and the correlation coefficient for each pair of measures. The median detection rate was calculated for each decile of practices ranked by conversion rate and vice versa, performing nonparametric tests for trend in each case.
RESULTS: Data for 8049 practices, 865 494 referrals, and 224 984 cancers were analysed. There were significant correlations between referral ratio and conversion rate (inverse) and detection rate (direct). There was also a direct correlation between conversion and detection rates. There was a significant trend in conversion rate for deciles of detection rate, and vice versa, with a marked difference between the lowest and higher deciles.
CONCLUSION: There is a consistent relationship between 2WW referral conversion rate and detection rate that can be interpreted as representing quality of clinical practice. The 2WW referral rate should not be a measure of quality of clinical care.

Entities:  

Mesh:

Year:  2012        PMID: 22947579      PMCID: PMC3426597          DOI: 10.3399/bjgp12X654551

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  16 in total

1.  Is the two week rule for cancer referrals working?

Authors:  R Jones; G Rubin; P Hungin
Journal:  BMJ       Date:  2001-06-30

2.  Emergency presentation of colorectal cancer is associated with poor 5-year survival.

Authors:  C S McArdle; D J Hole
Journal:  Br J Surg       Date:  2004-05       Impact factor: 6.939

Review 3.  A systematic review of cancer waiting time audits.

Authors:  R Lewis; R Collins; A Flynn; M Emmans Dean; L Myers; P Wilson; A Eastwood
Journal:  Qual Saf Health Care       Date:  2005-02

4.  Effect of deprivation on general practitioners' referral rates. Study should have used deprivation index that is independent of age.

Authors:  T Williams; A Jackson; D Turbitt
Journal:  BMJ       Date:  1997-10-04

5.  Case-mix and variation in specialist referrals in general practice.

Authors:  Caoimhe O Sullivan; Rumana Z Omar; Gareth Ambler; Azeem Majeed
Journal:  Br J Gen Pract       Date:  2005-07       Impact factor: 5.386

6.  A Wilcoxon-type test for trend.

Authors:  J Cuzick
Journal:  Stat Med       Date:  1985 Jan-Mar       Impact factor: 2.373

Review 7.  Variation in GP referral rates: what can we learn from the literature?

Authors:  C A O'Donnell
Journal:  Fam Pract       Date:  2000-12       Impact factor: 2.267

8.  'Two week wait' standards for suspected gynaecological malignancy. On target, but missing the point?

Authors:  Joanne Morrison; Siobhan Gillespie; I Z MacKenzie
Journal:  J Br Menopause Soc       Date:  2003-12

9.  Association between general practice referral rates and patients' socioeconomic status and access to specialised health care a population-based nationwide study.

Authors:  Torben Højmark Sørensen; Kim Rose Olsen; Peter Vedsted
Journal:  Health Policy       Date:  2009-04-24       Impact factor: 2.980

10.  Referral patterns, cancer diagnoses, and waiting times after introduction of two week wait rule for breast cancer: prospective cohort study.

Authors:  Shelley Potter; Sasi Govindarajulu; Mike Shere; Fiona Braddon; Geoffrey Curran; Rosemary Greenwood; Ajay K Sahu; Simon J Cawthorn
Journal:  BMJ       Date:  2007-07-13
View more
  39 in total

1.  New NICE guidance on diagnosing cancer in general practice.

Authors:  Jon Emery; Peter Vedsted
Journal:  Br J Gen Pract       Date:  2015-09       Impact factor: 5.386

2.  Diagnosis: shifting the ROC curve.

Authors:  Kevin Barraclough
Journal:  Br J Gen Pract       Date:  2012-09       Impact factor: 5.386

3.  Clinical outcome of head and neck cancer patients: a comparison between ENT patients referred via the 2 weeks wait pathway and alternative routes in the UK health system.

Authors:  B Y Winson Wong; S Fischer; H E Cruickshank
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-14       Impact factor: 2.503

4.  Assessment of cancer risk in men and women.

Authors:  Jon Emery
Journal:  Br J Gen Pract       Date:  2013-01       Impact factor: 5.386

5.  Direct access cancer testing in primary care: a systematic review of use and clinical outcomes.

Authors:  Claire Friedemann Smith; Alice C Tompson; Nicholas Jones; Josh Brewin; Elizabeth A Spencer; Clare R Bankhead; Fd Richard Hobbs; Brian D Nicholson
Journal:  Br J Gen Pract       Date:  2018-08-13       Impact factor: 5.386

Review 6.  The role of primary care in early detection and follow-up of cancer.

Authors:  Jon D Emery; Katie Shaw; Briony Williams; Danielle Mazza; Julia Fallon-Ferguson; Megan Varlow; Lyndal J Trevena
Journal:  Nat Rev Clin Oncol       Date:  2013-11-19       Impact factor: 66.675

7.  Primary care characteristics and stage of cancer at diagnosis using data from the national cancer registration service, quality outcomes framework and general practice information.

Authors:  Rebecca Maclean; Mona Jeffreys; Alex Ives; Tim Jones; Julia Verne; Yoav Ben-Shlomo
Journal:  BMC Cancer       Date:  2015-07-05       Impact factor: 4.430

8.  The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability.

Authors:  Mads Lind Ingeman; Morten Bondo Christensen; Flemming Bro; Søren T Knudsen; Peter Vedsted
Journal:  BMC Cancer       Date:  2015-05-20       Impact factor: 4.430

Review 9.  Socio-economic inequalities in stage at diagnosis, and in time intervals on the lung cancer pathway from first symptom to treatment: systematic review and meta-analysis.

Authors:  Lynne F Forrest; Sarah Sowden; Greg Rubin; Martin White; Jean Adams
Journal:  Thorax       Date:  2016-09-28       Impact factor: 9.139

10.  Socio-economic inequalities in patient, primary care, referral, diagnostic, and treatment intervals on the lung cancer care pathway: protocol for a systematic review and meta-analysis.

Authors:  Lynne F Forrest; Sarah Sowden; Greg Rubin; Martin White; Jean Adams
Journal:  Syst Rev       Date:  2014-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.